IP Library Granted Patent US 7,271,243
Granted Patent B2
US 7,271,243 · App. 10/643,836 · Granted Sep 18, 2007

Full-length human cDNAs encoding potentially secreted proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,271,243
App. No.
10/643,836
Granted
Sep 18, 2007
Kind
B2
Abstract

The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.

Claims (16)

1. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 297 or the amino acid sequence of the polypeptide having the internal designation of 181-3-3-0-C9-CS as encoded by a human cDNA in ATCC accession number PTA-1218.

2. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO: 297.

3. The polypeptide of claim 2 , wherein said polypeptide plays a role in vesicle trafficking.

4. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence of the polypeptide having the internal designation of 181-3-3-0-C9-CS as encoded by a human cDNA in ATCC accession number PTA-1218.

5. The polypeptide of claim 4 , wherein said polypeptide plays a role in vesicle trafficking.

6. The polypeptide of claim 1 , wherein said polypeptide consists of the amino acid sequence of SEQ ID NO: 297.

7. The polypeptide of claim 6 , wherein said polypeptide plays a role in vesicle trafficking.

8. The polypeptide of claim 1 , where said polypeptide plays a role in vesicle trafficking.

9. A composition comprising an isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 297 or the amino acid sequence of the polypeptide having the internal designation of 181 -3-3-0-C9-CS as encoded by a human cDNA in ATCC accession number PTA-1218.

10. The composition of claim 9 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO: 297.

11. The composition of claim 10 , wherein said polypeptide plays a role in vesicle trafficking.

12. The composition of claim 9 , wherein said polypeptide comprises the amino acid sequence of the polypeptide having the internal designation of 181-3-3-0-C9-CS as encoded by a human cDNA in ATCC accession number PTA-12 18.

13. The composition of claim 12 , wherein said polypeptide plays a role in vesicle trafficking.

14. The composition of claim 9 , wherein said polypeptide consists of the amino acid sequence of SEQ ID NO: 297.

15. The composition of claim 14 , wherein said polypeptide plays a role in vesicle trafficking.

16. The composition of claim 9 , where said polypeptide plays a role in vesicle trafficking.

Assignments (2)
CHANGE OF NAME Recorded Aug 3, 2005
From: GENSET S.A.
To: SERONO GENETICS INSTITUTE S.A.
Reel/Frame 016348/0865 →
CORRECTION TO THE COVER SHEET (CHANGE OF NAME) Recorded Oct 3, 2003
From: EDWARDS, JEAN-BAPTISTE DUMAS MILNE; BOUGUELERET, LYDIE; JOBERT, SEVERIN
To: GENSET, S.A.
Reel/Frame 014025/0399 →